{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:56:51Z","timestamp":1791111411419,"version":"4.1.0"},"reference-count":129,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"vor","delay-in-days":1784,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AG031852"],"award-info":[{"award-number":["AG031852"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AG026151"],"award-info":[{"award-number":["AG026151"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.bbadis.2009.10.007","type":"journal-article","created":{"date-parts":[[2009,10,22]],"date-time":"2009-10-22T09:06:07Z","timestamp":1256202367000},"page":"212-220","source":"Crossref","is-referenced-by-count":246,"title":["Mitochondria: A therapeutic target in neurodegeneration"],"prefix":"10.1016","volume":"1802","author":[{"given":"Paula I.","family":"Moreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoung-gon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Nunomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2009.10.007_bib1","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1089\/ars.2007.1703","article-title":"Alzheimer's disease: a lesson from mitochondrial dysfunction","volume":"9","author":"Moreira","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2009.10.007_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/bse0330043","article-title":"Mitochondria in the life and death of neurons","volume":"33","author":"Budd","year":"1998","journal-title":"Essays Biochem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nrm1763","article-title":"Radical medicine: treating ageing to cure disease","volume":"6","author":"Finkel","year":"2005","journal-title":"Nat. Rev., Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2009.10.007_bib4","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1089\/neu.2000.17.843","article-title":"Mitochondrial participation in ischemic and traumatic neural cell death","volume":"17","author":"Fiskum","year":"2000","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bbadis.2009.10.007_bib5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1089\/neu.1998.15.789","article-title":"Traumatic brain injury alters synaptic homeostasis: implications for impaired mitochondrial and transport function","volume":"15","author":"Sullivan","year":"1998","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bbadis.2009.10.007_bib6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3233\/JAD-2009-0972","article-title":"An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease","volume":"16","author":"Moreira","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2009.10.007_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbadis.2009.10.007_bib8","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.freeradbiomed.2008.01.002","article-title":"Nucleic acid oxidation in Alzheimer disease","volume":"44","author":"Moreira","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2009.10.007_bib9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","article-title":"Oxidative damage is the earliest event in Alzheimer disease","volume":"60","author":"Nunomura","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2009.10.007_bib10","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","article-title":"Mitochondrial abnormalities in Alzheimer's disease","volume":"21","author":"Hirai","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.10.007_bib11","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","article-title":"Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression","volume":"15","author":"Manczak","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2009.10.007_bib12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ana.20474","article-title":"Mitochondrial abnormalities in Alzheimer brain: mechanistic implications","volume":"57","author":"Bubber","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2009.10.007_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jnr.10756","article-title":"Inhibition of alpha-ketoglutarate dehydrogenase complex promotes cytochrome c release from mitochondria, caspase-3 activation, and necrotic cell death","volume":"74","author":"Huang","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2009.10.007_bib14","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1471-4159.1992.tb09439.x","article-title":"Brain cytochrome oxidase in Alzheimer's disease","volume":"59","author":"Kish","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib15","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1212\/WNL.44.6.1086","article-title":"Reduced platelet cytochrome c oxidase activity in Alzheimer's disease","volume":"44","author":"Parker","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2009.10.007_bib16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0197-4580(01)00314-1","article-title":"Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease","volume":"23","author":"Bosetti","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2009.10.007_bib17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.mito.2006.10.004","article-title":"Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment","volume":"6","author":"Valla","year":"2006","journal-title":"Mitochondrion"},{"key":"10.1016\/j.bbadis.2009.10.007_bib18","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1096\/fj.00-0561fje","article-title":"Functional mitochondria are required for amyloid beta-mediated neurotoxicity","volume":"15","author":"Cardoso","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2009.10.007_bib19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.expneurol.2005.07.012","article-title":"CoQ10 therapy attenuates amyloid beta-peptide toxicity in brain mitochondria isolated from aged diabetic rats","volume":"196","author":"Moreira","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2009.10.007_bib20","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.nbd.2004.10.017","article-title":"Insulin protects against amyloid beta-peptide toxicity in brain mitochondria of diabetic rats","volume":"18","author":"Moreira","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2009.10.007_bib21","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/10715760802159057","article-title":"Effects of amyloid-beta peptides on hydrogen peroxide-metabolizing enzymes in rat brain in vivo","volume":"42","author":"Kaminsky","year":"2008","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bbadis.2009.10.007_bib22","doi-asserted-by":"crossref","first-page":"51654","DOI":"10.1074\/jbc.M404500200","article-title":"Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria","volume":"279","author":"Hansson","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib23","doi-asserted-by":"crossref","first-page":"50310","DOI":"10.1074\/jbc.M405600200","article-title":"Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis","volume":"279","author":"Keil","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib24","first-page":"143","article-title":"Metal ions and oxidative protein modification in neurological disease","volume":"41","author":"Sayre","year":"2005","journal-title":"Ann. Ist. Super Sanita"},{"key":"10.1016\/j.bbadis.2009.10.007_bib25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1023\/A:1015536808304","article-title":"Amyloid beta-peptide promotes permeability transition pore in brain mitochondria","volume":"21","author":"Moreira","year":"2001","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bbadis.2009.10.007_bib26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jnr.10282","article-title":"Effect of amyloid beta-peptide on permeability transition pore: a comparative study","volume":"69","author":"Moreira","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2009.10.007_bib27","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/nm.1868","article-title":"Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease","volume":"14","author":"Du","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2009.10.007_bib28","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2353\/ajpath.2008.071208","article-title":"Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients","volume":"173","author":"Wang","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2009.10.007_bib29","doi-asserted-by":"crossref","first-page":"19318","DOI":"10.1073\/pnas.0804871105","article-title":"Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission\/fusion proteins","volume":"105","author":"Wang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2009.10.007_bib30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1126\/science.1171091","article-title":"S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury","volume":"324","author":"Cho","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2009.10.007_bib31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.jnen.0000240476.73532.b0","article-title":"Autophagocytosis of mitochondria is prominent in Alzheimer disease","volume":"66","author":"Moreira","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2009.10.007_bib32","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4161\/auto.4872","article-title":"Increased autophagic degradation of mitochondria in Alzheimer disease","volume":"3","author":"Moreira","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2009.10.007_bib33","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib34","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1471-4159.1992.tb09789.x","article-title":"Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement","volume":"58","author":"Cleeter","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/mcne.2000.0921","article-title":"Akt1\/PKBalpha protects PC12 cells against the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium and reduces the levels of oxygen-free radicals","volume":"17","author":"Salinas","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbadis.2009.10.007_bib36","doi-asserted-by":"crossref","first-page":"42026","DOI":"10.1074\/jbc.M508628200","article-title":"Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication","volume":"280","author":"Panov","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib37","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1196\/annals.1410.009","article-title":"Rotenone damages striatal organotypic slice culture","volume":"1148","author":"Moldzio","year":"2008","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2009.10.007_bib38","doi-asserted-by":"crossref","first-page":"10056","DOI":"10.1074\/jbc.M512203200","article-title":"Persistent S-nitrosation of complex I and other mitochondrial membrane proteins by S-nitrosothiols but not nitric oxide or peroxynitrite: implications for the interaction of nitric oxide with mitochondria","volume":"281","author":"Dahm","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF03033365","article-title":"Calpain-mediated MPP+ toxicity in mitochondrial DNA depleted cells","volume":"13","author":"Domingues","year":"2008","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbadis.2009.10.007_bib40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.mito.2008.03.004","article-title":"Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background","volume":"8","author":"Esteves","year":"2008","journal-title":"Mitochondrion"},{"key":"10.1016\/j.bbadis.2009.10.007_bib41","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/ars.2008.2247","article-title":"Oxidative stress involvement in alpha-synuclein oligomerization in Parkinson's disease cybrids","volume":"11","author":"Esteves","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2009.10.007_bib42","doi-asserted-by":"crossref","first-page":"e5491","DOI":"10.1371\/journal.pone.0005491","article-title":"Involvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP\/MPP-treated neurons","volume":"4","author":"Petit-Paitel","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbadis.2009.10.007_bib43","doi-asserted-by":"crossref","first-page":"e4597","DOI":"10.1371\/journal.pone.0004597","article-title":"PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson's disease","volume":"4","author":"Liu","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbadis.2009.10.007_bib44","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/cdd.2008.166","article-title":"Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response","volume":"16","author":"Moisoi","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2009.10.007_bib45","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2009.10.007_bib46","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1073\/pnas.0609833104","article-title":"Selective defect of in vivo glycolysis in early Huntington's disease striatum","volume":"104","author":"Powers","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2009.10.007_bib47","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbrc.2007.05.093","article-title":"Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients","volume":"359","author":"Chen","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2009.10.007_bib48","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1074\/jbc.M704704200","article-title":"Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease","volume":"283","author":"Lim","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib49","doi-asserted-by":"crossref","first-page":"34785","DOI":"10.1074\/jbc.M603845200","article-title":"Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences","volume":"281","author":"Milakovic","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib50","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1471-4159.2007.04996.x","article-title":"Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease","volume":"104","author":"Pandey","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pnpbp.2008.10.013","article-title":"Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain","volume":"33","author":"Kumar","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbadis.2009.10.007_bib52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.molbrainres.2004.10.033","article-title":"3-Nitropropionic acid-induced hydrogen peroxide, mitochondrial DNA damage, and cell death are attenuated by Bcl-2 overexpression in PC12 cells","volume":"133","author":"Mandavilli","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.bbadis.2009.10.007_bib53","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/00004647-200207000-00005","article-title":"Involvement of superoxide in excitotoxicity and DNA fragmentation in striatal vulnerability in mice after treatment with the mitochondrial toxin, 3-nitropropionic acid","volume":"22","author":"Kim","year":"2002","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbadis.2009.10.007_bib54","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.dnarep.2008.09.004","article-title":"Mitochondrial DNA damage is a hallmark of chemically induced and the R6\/2 transgenic model of Huntington's disease","volume":"8","author":"Acevedo-Torres","year":"2009","journal-title":"DNA Repair (Amst.)"},{"key":"10.1016\/j.bbadis.2009.10.007_bib55","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","article-title":"N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking","volume":"28","author":"Orr","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.10.007_bib56","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1046\/j.1471-4159.2002.01045.x","article-title":"Selective loss of neurofilament expression in Cu\/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis","volume":"82","author":"Menzies","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib57","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000085063","article-title":"Mitochondria in amyotrophic lateral sclerosis: a trigger and a target","volume":"1","author":"Dupuis","year":"2004","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.bbadis.2009.10.007_bib58","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1471-4159.2007.04502.x","article-title":"Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels","volume":"102","author":"Zimmerman","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib59","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1124\/mol.108.050831","article-title":"Cu\/Zn superoxide dismutase typical for familial amyotrophic lateral sclerosis increases the vulnerability of mitochondria and perturbs Ca2+ homeostasis in SOD1G93A mice","volume":"75","author":"Jaiswal","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbadis.2009.10.007_bib60","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1523\/JNEUROSCI.5308-07.2008","article-title":"Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants","volume":"28","author":"Cassina","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.10.007_bib61","doi-asserted-by":"crossref","first-page":"28321","DOI":"10.1074\/jbc.M805599200","article-title":"Lysyl-tRNA synthetase is a target for mutant SOD1 toxicity in mitochondria","volume":"283","author":"Kawamata","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib62","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/00004728-198807000-00019","article-title":"Cortical motor-sensory hypometabolism in amyotrophic lateral sclerosis: a PET study","volume":"12","author":"Hatazawa","year":"1988","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.bbadis.2009.10.007_bib63","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8","article-title":"Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death","volume":"46","author":"Borthwick","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2009.10.007_bib64","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00401-004-0939-7","article-title":"Ultrastructural study of aggregates in the spinal cord of transgenic mice with a G93A mutant SOD1 gene","volume":"109","author":"Sasaki","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2009.10.007_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pscychresns.2008.07.015","article-title":"Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy","volume":"173","author":"Pilatus","year":"2009","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbadis.2009.10.007_bib66","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3727\/000000005783982756","article-title":"Creatine supplementation improves dopaminergic cell survival and protects against MPP+ toxicity in an organotypic tissue culture system","volume":"14","author":"Andres","year":"2005","journal-title":"Cell Transplant"},{"key":"10.1016\/j.bbadis.2009.10.007_bib67","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.neuroscience.2005.03.004","article-title":"Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue","volume":"133","author":"Andres","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2009.10.007_bib68","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/exnr.1999.7049","article-title":"Creatine and cyclocreatine attenuate MPTP neurotoxicity","volume":"157","author":"Matthews","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2009.10.007_bib69","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1523\/JNEUROSCI.1278-04.2004","article-title":"Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice","volume":"24","author":"Zhu","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2009.10.007_bib70","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0006-8993(00)02038-2","article-title":"Neuroprotective effects of creatine administration against NMDA and malonate toxicity","volume":"860","author":"Malcon","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2009.10.007_bib71","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2004.11.003","article-title":"The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses","volume":"119","author":"Li","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2009.10.007_bib72","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/6568","article-title":"Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis","volume":"5","author":"Klivenyi","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2009.10.007_bib73","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1046\/j.1471-4159.2000.0741968.x","article-title":"Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons","volume":"74","author":"Brewer","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib74","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/1531-8249(200011)48:5<723::AID-ANA5>3.0.CO;2-W","article-title":"Dietary supplement creatine protects against traumatic brain injury","volume":"48","author":"Sullivan","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2009.10.007_bib75","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/sj.jcbfm.9600351","article-title":"Improved reperfusion and neuroprotection by creatine in a mouse model of stroke","volume":"27","author":"Prass","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbadis.2009.10.007_bib76","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng1769","article-title":"High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease","volume":"38","author":"Bender","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2009.10.007_bib77","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.nutres.2008.01.001","article-title":"Long-term creatine supplementation is safe in aged patients with Parkinson disease","volume":"28","author":"Bender","year":"2008","journal-title":"Nutr. Res."},{"key":"10.1016\/j.bbadis.2009.10.007_bib78","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/01.wnl.0000194318.74946.b6","article-title":"Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2\u2032dG","volume":"66","author":"Hersch","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2009.10.007_bib79","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.WNL.0000090629.40891.4B","article-title":"Creatine supplementation in Huntington's disease: a placebo-controlled pilot trial","volume":"61","author":"Verbessem","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2009.10.007_bib80","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1212\/01.WNL.0000142992.81995.F0","article-title":"A clinical trial of creatine in ALS","volume":"63","author":"Shefner","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2009.10.007_bib81","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0167-4943(01)00104-2","article-title":"Alpha-lipoic acid as a new treatment option for Azheimer type dementia","volume":"32","author":"Hager","year":"2001","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.bbadis.2009.10.007_bib82","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-3-211-73574-9_24","article-title":"Alpha-lipoic acid as a new treatment option for Alzheimer's disease\u2014a 48\u00a0months follow-up analysis","author":"Hager","year":"2007","journal-title":"J. Neural Transm., Suppl."},{"key":"10.1016\/j.bbadis.2009.10.007_bib83","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3233\/JAD-2007-12210","article-title":"Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts","volume":"12","author":"Moreira","year":"2007","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2009.10.007_bib84","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.freeradbiomed.2006.11.006","article-title":"Involvement of PI3K\/PKG\/ERK1\/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-l-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease","volume":"42","author":"Abdul","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2009.10.007_bib85","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.abb.2003.12.020","article-title":"(R)-alpha-lipoic acid reverses the age-related loss in GSH redox status in post-mitotic tissues: evidence for increased cysteine requirement for GSH synthesis","volume":"423","author":"Suh","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbadis.2009.10.007_bib86","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1097\/00001756-200110290-00044","article-title":"Lipoic acid improves survival in transgenic mouse models of Huntington's disease","volume":"12","author":"Andreassen","year":"2001","journal-title":"NeuroReport"},{"key":"10.1016\/j.bbadis.2009.10.007_bib87","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neurobiolaging.2005.12.014","article-title":"Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice","volume":"28","author":"Quinn","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2009.10.007_bib88","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1582-4934.2008.00324.x","article-title":"Neuronal mitochondrial amelioration by feeding acetyl-l-carnitine and lipoic acid to aged rats","volume":"13","author":"Aliev","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbadis.2009.10.007_bib89","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jns.2009.03.002","article-title":"The effect of acetyl-l-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease","volume":"283","author":"Shenk","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2009.10.007_bib90","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/03007995.2020.12102584","article-title":"Effects of acetyl-l-carnitine in Alzheimer's disease patients unresponsive to acetylcholinesterase inhibitors","volume":"19","author":"Bianchetti","year":"2003","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.bbadis.2009.10.007_bib91","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00004850-200303000-00001","article-title":"Meta-analysis of double blind randomized controlled clinical trials of acetyl-l-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease","volume":"18","author":"Montgomery","year":"2003","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbadis.2009.10.007_bib92","first-page":"CD003158","article-title":"Acetyl-l-carnitine for dementia","author":"Hudson","year":"2003","journal-title":"Cochrane Database Syst. Rev. (Online)"},{"key":"10.1016\/j.bbadis.2009.10.007_bib93","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1023\/B:JOBB.0000041772.74810.92","article-title":"Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment","volume":"36","author":"Beal","year":"2004","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.bbadis.2009.10.007_bib94","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.nbd.2004.10.021","article-title":"Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by Coenzyme Q10","volume":"18","author":"Somayajulu","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2009.10.007_bib95","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1471-4159.2005.03112.x","article-title":"Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10","volume":"93","author":"Moon","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib96","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.taap.2004.04.019","article-title":"Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble coenzyme Q10","volume":"201","author":"McCarthy","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbadis.2009.10.007_bib97","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1385\/JMN:28:2:125","article-title":"Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons","volume":"28","author":"Kooncumchoo","year":"2006","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbadis.2009.10.007_bib98","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbrc.2005.02.132","article-title":"Preformed beta-amyloid fibrils are destabilized by coenzyme Q10 in vitro","volume":"330","author":"Ono","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2009.10.007_bib99","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/biof.5520250111","article-title":"Coenzyme Q10 protects SHSY5Y neuronal cells from beta amyloid toxicity and oxygen-glucose deprivation by inhibiting the opening of the mitochondrial permeability transition pore","volume":"25","author":"Li","year":"2005","journal-title":"BioFactors"},{"key":"10.1016\/j.bbadis.2009.10.007_bib100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12031-007-9033-7","article-title":"Coenzyme Q10 attenuates beta-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation","volume":"34","author":"Yang","year":"2008","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbadis.2009.10.007_bib101","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainresbull.2005.11.019","article-title":"Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson's disease and the neuroprotective role of coenzyme Q10","volume":"70","author":"Sharma","year":"2006","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbadis.2009.10.007_bib102","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1471-4159.2007.05097.x","article-title":"Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism","volume":"104","author":"Cleren","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib103","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbadis.2006.03.004","article-title":"Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice","volume":"1762","author":"Smith","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2009.10.007_bib104","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbadis.2005.11.002","article-title":"Combination therapy using minocycline and coenzyme Q10 in R6\/2 transgenic Huntington's disease mice","volume":"1762","author":"Stack","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2009.10.007_bib105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0169-409X(99)00069-1","article-title":"Drug delivery to mitochondria: the key to mitochondrial medicine","volume":"41","author":"Murphy","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbadis.2009.10.007_bib106","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1432-1327.1999.00543.x","article-title":"Selective targeting of an antioxidant to mitochondria","volume":"263","author":"Smith","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib107","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1096\/fj.03-0240fje","article-title":"Mitochondria-targeted antioxidants protect Friedreich ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants","volume":"17","author":"Jauslin","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2009.10.007_bib108","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainres.2005.06.030","article-title":"Mitochondrially targeted vitamin E and vitamin E mitigate ethanol-mediated effects on cerebellar granule cell antioxidant defense systems","volume":"1052","author":"Siler-Marsiglio","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2009.10.007_bib109","first-page":"241","article-title":"The mode of action of lipid-soluble antioxidants in biological membranes: relationship between the effects of ubiquinol and vitamin E as inhibitors of lipid peroxidation in submitochondrial particles","volume":"3","author":"Ernster","year":"1992","journal-title":"BioFactors"},{"key":"10.1016\/j.bbadis.2009.10.007_bib110","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1074\/jbc.M611463200","article-title":"Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases","volume":"282","author":"James","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib111","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1074\/jbc.M009093200","article-title":"Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties","volume":"276","author":"Kelso","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib112","doi-asserted-by":"crossref","first-page":"21295","DOI":"10.1074\/jbc.M501527200","article-title":"Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools","volume":"280","author":"James","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib113","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/nm1001-1111","article-title":"Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells","volume":"7","author":"Hwang","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2009.10.007_bib114","doi-asserted-by":"crossref","first-page":"16510","DOI":"10.1074\/jbc.M301089200","article-title":"Redox regulation of cAMP-responsive element-binding protein and induction of manganous superoxide dismutase in nerve growth factor-dependent cell survival","volume":"278","author":"Bedogni","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib115","doi-asserted-by":"crossref","first-page":"37575","DOI":"10.1074\/jbc.M404003200","article-title":"Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis","volume":"279","author":"Dhanasekaran","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib116","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1089\/ars.2007.1865","article-title":"Is antioxidant potential of the mitochondrial targeted ubiquinone derivative MitoQ conserved in cells lacking mtDNA?","volume":"10","author":"Lu","year":"2008","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2009.10.007_bib117","doi-asserted-by":"crossref","first-page":"31372","DOI":"10.1155\/JBB\/2006\/31372","article-title":"Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics","volume":"2006","author":"Reddy","year":"2006","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.bbadis.2009.10.007_bib118","doi-asserted-by":"crossref","first-page":"E521","DOI":"10.1208\/aapsj080362","article-title":"Mitochondria-targeted peptide antioxidants: novel neuroprotective agents","volume":"8","author":"Szeto","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.bbadis.2009.10.007_bib119","doi-asserted-by":"crossref","first-page":"34682","DOI":"10.1074\/jbc.M402999200","article-title":"Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury","volume":"279","author":"Zhao","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib120","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.bcp.2005.08.022","article-title":"Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines","volume":"70","author":"Zhao","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2009.10.007_bib121","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1471-4159.2006.04018.x","article-title":"Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis","volume":"98","author":"Petri","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2009.10.007_bib122","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1089\/ars.2009.2445","article-title":"Mitochondria targeted peptides protect against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine neurotoxicity","volume":"11","author":"Yang","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2009.10.007_bib123","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1749-6632.2001.tb03654.x","article-title":"Antihistamine agent Dimebon as a novel neuroprotector and a cognition enhancer","volume":"939","author":"Bachurin","year":"2001","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2009.10.007_bib124","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(08)61074-0","article-title":"Effect of Dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study","volume":"372","author":"Doody","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2009.10.007_bib125","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1023\/B:BEBM.0000017097.75818.14","article-title":"Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons","volume":"136","author":"Grigorev","year":"2003","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.bbadis.2009.10.007_bib126","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0409402102","article-title":"Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease","volume":"102","author":"Tang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2009.10.007_bib127","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-1326-3-15","article-title":"Evaluation of Dimebon in cellular model of Huntington's disease","volume":"3","author":"Wu","year":"2008","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbadis.2009.10.007_bib128","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1023\/A:1017972709652","article-title":"Dimebon and tacrine inhibit neurotoxic action of beta-amyloid in culture and block L-type Ca(2+) channels","volume":"132","author":"Lermontova","year":"2001","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.bbadis.2009.10.007_bib129","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1749-6632.2003.tb07541.x","article-title":"Mitochondria as a target for neurotoxins and neuroprotective agents","volume":"993","author":"Bachurin","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443909002439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443909002439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T03:30:14Z","timestamp":1710646214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443909002439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":129,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0925443909002439"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2009.10.007","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}